Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivaroxaban Safety Profile in the Prophylaxis of Venous Thromboembolism After Hip Fracture Surgery

NCT01509118 is registered in ClinicalTrials.gov with Phramongkutklao College of Medicine and Hospital as lead sponsor.

NCT NCT01509118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01509118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivaroxaban Safety Profile in the Prophylaxis of Venous Thromboembolism After Hip Fracture Surgery
Lead sponsor
Phramongkutklao College of Medicine and Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2011
Completion date
September 30, 2013
Enrollment
500 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

open fracture of hip